- Home
- NAMS vs BELFA Comparison
NAMS vs BELFA Comparison
Compare NAMS & BELFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAMS | BELFA |
|---|---|---|
| Founded | 2019 | 1949 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.3B |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | NAMS | BELFA |
|---|---|---|
| Price | $27.93 | $237.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $46.75 | ★ $174.25 |
| AVG Volume (30 Days) | ★ 1.1M | 176.3K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.10% |
| EPS Growth | ★ 32.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $22,503,000.00 | ★ $491,611,000.00 |
| Revenue This Year | $17.96 | $9.74 |
| Revenue Next Year | $540.65 | $6.34 |
| P/E Ratio | ★ N/A | $40.02 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.05 | $108.00 |
| 52 Week High | $42.21 | $293.51 |
Technical Indicators
Market Signals| Indicator | NAMS | BELFA |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 52.71 |
| Support Level | $25.74 | $210.33 |
| Resistance Level | $37.29 | $244.17 |
| Average True Range (ATR) | 1.37 | 14.18 |
| MACD | -0.01 | 2.28 |
| Stochastic Oscillator | 36.04 | 85.30 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About BELFA Bel Fuse Inc.
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.